153 related articles for article (PubMed ID: 30290717)
1. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis.
Barbado J; Tabera S; Sánchez A; García-Sancho J
Lupus; 2018 Nov; 27(13):2161-2165. PubMed ID: 30290717
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study.
Wang D; Li J; Zhang Y; Zhang M; Chen J; Li X; Hu X; Jiang S; Shi S; Sun L
Arthritis Res Ther; 2014 Mar; 16(2):R79. PubMed ID: 24661633
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.
Gu F; Wang D; Zhang H; Feng X; Gilkeson GS; Shi S; Sun L
Clin Rheumatol; 2014 Nov; 33(11):1611-9. PubMed ID: 25119864
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
5. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial.
Ranjbar A; Hassanzadeh H; Jahandoust F; Miri R; Bidkhori HR; Monzavi SM; Sanjar-Moussavi N; Matin MM; Shariati-Sarabi Z
Curr Res Transl Med; 2022 May; 70(2):103324. PubMed ID: 34979487
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Mesenchymal Stem Cell Therapy on Lupus Nephritis and Renal Function in Systemic Lupus Erythematosus: A Meta-Analysis.
Xia Y; Ye H; Li K; Shi B; Sun X; Wu J
Clin Invest Med; 2023 Mar; 46(1):E24-35. PubMed ID: 36966389
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience.
Wang D; Zhang H; Liang J; Li X; Feng X; Wang H; Hua B; Liu B; Lu L; Gilkeson GS; Silver RM; Chen W; Shi S; Sun L
Cell Transplant; 2013; 22(12):2267-77. PubMed ID: 24388428
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
[TBL] [Abstract][Full Text] [Related]
11. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study.
Liang J; Zhang H; Hua B; Wang H; Lu L; Shi S; Hou Y; Zeng X; Gilkeson GS; Sun L
Ann Rheum Dis; 2010 Aug; 69(8):1423-9. PubMed ID: 20650877
[TBL] [Abstract][Full Text] [Related]
12. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients.
Matsumura R; Umemiya K; Sugiyama T; Sueishi M; Umibe T; Ichikawa K; Yoshimura M;
Clin Exp Rheumatol; 2009; 27(3):416-21. PubMed ID: 19604433
[TBL] [Abstract][Full Text] [Related]
14. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
16. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
17. Infusion of Human Bone Marrow-Derived Mesenchymal Stem Cells Alleviates Autoimmune Nephritis in a Lupus Model by Suppressing Follicular Helper T-Cell Development.
Jang E; Jeong M; Kim S; Jang K; Kang BK; Lee DY; Bae SC; Kim KS; Youn J
Cell Transplant; 2016; 25(1):1-15. PubMed ID: 25975931
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
He D; Liu M; Liu B
Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
[TBL] [Abstract][Full Text] [Related]
19. Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritis.
Thiel A; Yavanian G; Nastke MD; Morales P; Kouris NA; Kimbrel EA; Lanza R
Sci Rep; 2015 Dec; 5():17685. PubMed ID: 26628350
[TBL] [Abstract][Full Text] [Related]
20. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation.
Choi EW; Shin IS; Park SY; Park JH; Kim JS; Yoon EJ; Kang SK; Ra JC; Hong SH
Arthritis Rheum; 2012 Jan; 64(1):243-53. PubMed ID: 21904997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
